1. Bhandari, M, Swiontkowski, M. Management of acute hip fracture. N Engl J Med. 2017;377:2053-2062.
Google Scholar | Crossref | Medline2. Gupta, P, Kang, KK, Pasternack, JB, Klein, E, Feierman, DE. Perioperative transfusion associated with increased morbidity and mortality in geriatric patients undergoing hip fracture surgery. Geriatr Orthop Surg Rehabil. 2021;12:21514593211015118.
Google Scholar | SAGE Journals3. Adams, JD, Marshall, WA. The use of tranexamic acid in hip and pelvic fracture surgeries. J Am Acad Orthop Surg. 2021;29(12):e576-e583.
Google Scholar | Crossref | Medline4. Farrow, LS, Smith, TO, Ashcroft, GP, Myint, PK. A systematic review of tranexamic acid in hip fracture surgery. Br J Clin Pharmacol. 2016;82:1458-1470.
Google Scholar | Crossref | Medline5. Gibon, E, Courpied, JP, Hamadouche, M. Total joint replacement and blood loss: what is the best equation? Int Orthop. 2013;37(4):735-739.
Google Scholar | Crossref | Medline6. Zufferey, PJ, Miquet, M, Quenet, S, et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth. 2010;104(1):23-30.
Google Scholar | Crossref | Medline | ISI7. Taeuber, I, Weibel, S, Herrmann, E, et al. Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. JAMA Surg. 2021;156(6):e210884.
Google Scholar | Crossref8. Zak, SG, Tang, A, Sharan, M, Waren, D, Rozell, JC, Schwarzkopf, R. Tranexamic acid is safe in patients with a history of coronary artery disease undergoing total joint arthroplasty. J Bone Joint Surg Am. 2021;103(10):900-904.
Google Scholar | Crossref | Medline9. Harper, KD, Navo, P, Ramsey, F, Jallow, S, Rehman, S. “Hidden” preoperative blood loss with extracapsular versus intracapsular hip fractures: what is the difference? Geriatr Orthop Surg Rehabil. 2017;8(4):202-207.
Google Scholar | SAGE Journals | ISI